alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                    Exhibit 4.71

 FIRST AMENDMENT TO THE PROCUREMENT AND INSTALLATION OF MSOAN DIVRE-I SUMATERA
          PACKAGE III NO. 425/HK820/ITS-00/2006 DATED 29 DECEMBER 2006

<TABLE>
<S>                     <C>
Parties:                1.   TELKOM; and

                        2.   PT Industri Telekomunikasi Indonesia ("INTI").

Preceding Agreement:    Main agreement No. 140/HK.810/ITS-00/2006 dated 29 June
                        2006.

Deadline of
Work Completion:        Not later than 19 December 2006.

Performance bond:       within 14 calendar days since 29 December 2006, INTI
                        must submit the performance bond in form of bank
                        guarantee issued by government bank or private national
                        bank or private foreign bank or surety bond issued by
                        insurance company determined by TELKOM.
</TABLE>
NOTE: This order is nonprecedential.



## United States Court of Appeals for the Federal Circuit 2009-3006 CHARLES G. MORGAN,

Petitioner
v. DEPARTMENT OF ENERGY,

Respondent. Petition for review of the Merit Systems Protection Board in

SF1221080135-W-1. ON MOTION Before LINN, Circuit Judge. ORDER Charles G. Morgan moves for a 60-day extension of time, until June 23, 2009, to file his brief. Upon consideration thereof, IT IS ORDERED THAT: The motion is granted. No further 

### extensions should be anticipated. FOR THE COURT 

# APR 2 0 2009 /s/ Jan Horbaly Date Richard Segerblom, Esq. Jane W. Vanneman, Esq. Jan Horbaly Clerk COURNEAREALS FOR THE FEDERAL CIRCUIT
APR 2 0 2009

CLERK CC: s17
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-56996, 333-96825 and 333-110905 on
Form S-8 and Registration Statement No. 333-116543 on Form S-3 of our reports dated March 14, 2005, relating to the consolidated
financial statements of deCODE genetics, Inc., and management's report on the effectiveness of internal control over financial reporting, appearing in this Annual Report on
Form 10-K of deCODE genetics, Inc. for the year ended December 31, 2004.

/s/
DELOITTE & TOUCHE LLP

Boston,
Massachusetts
March 14, 2005

---



QuickLinks
**Exhibit 32.1**

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Southern Copper Corporation(the “Company”) on Form 10-K for the period ending December 31, 2005as filed with the Securities and Exchange Commission on the date hereof (the “Report”),I, Oscar Gonzalez Rocha President and Chief Executive Officer of the Company,certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)           The Reportfully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2)           Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
|                       |                                   | /s/ Oscar  Gonzalez Rocha |   |   |
|----------------------------|----------------------------------------|---------------------------|--------|--------|
|                       | Oscar Gonzalez Rocha                   |                      |
|                       | President  and Chief Executive Officer |                      |
|                       |                                   |                      |
|                       |                                   |                      |
| Date: August 29, 2006 |                                   |                      |

 

A signed original of this written statement required by section 906has been provided to Southern Copper Corporation and will be retained bySouthern Copper Corporation and furnished to the Securities and ExchangeCommission or its staff upon request.

 

----
MAINE ARMY NATIONAL GUARD (MEARNG) DRINKING WATER PFAS SNAPSHOT 

The Army National Guard is committed to ensuring quality drinking water is provided to its 

Soldiers, and civilians. Proactive sampling is performed by the Army National Guard on its

drinking water systems, as well as, coordination with other purveyors to ensure perfluorooctane 

sulfonate (PFOS) and perfluorooctanoic acid (PFOA) remains below the Environmental 

Protection Agency (EPA) lifetime health advisory (HA) level of 70 parts per trillion (ppt). The 

EPA HA is not an enforceable or a regulatory standard, and represents a concentration in 

drinking water that is not expected to produce adverse health effects if the water is consumed 

over a lifetime.

Drinking Water Status: Finished drinking water, which is the treated water people drink at Bog 

Brook Training Site does not contain PFOS/PFOA above the EPA HA. Additionally, Army 

National Guard-provided drinking water complies with the standards of the Safe Drinking Water 

Act (SDWA), a federal law designed to protect the quality of drinking water supplied to the 

American public. The Army National Guard will continue to monitor on-base drinking water to 

ensure the EPA HA or a properly promulgated state drinking water standard is not exceeded.

Test Date: Mar 2023

PFOA + PFOS Results: 0.00 ppt. 

Future Testing Event: Mar 2026 

Type of Drinking Water System: Army National Guard-owned

For Questions Contact: Maine National Guard State Public Affairs Office

Office Phone Number: 207-430-5759

Office E-mail Address: ng.me.mearng.list.public-affairs@mail.mil

Water Quality Reports: “A water quality report is not required for this location”
kpmg.htm













 


Consent of Independent Registered Public Accounting Firm


 


The Board of Directors


Kansas City Life Insurance Company:


 


We consent to the use of our report dated February 28, 2013 with respect to the consolidated balance sheets of Kansas City Life Insurance Company (the Company) and subsidiaries as of December 31, 2012 and 2011, and the related consolidated statements of comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2012, and all related financial statement schedules, and the effectiveness of internal control over financial reporting as of December 31, 2012; and to the use of our report dated April 26, 2013 with respect to the statement of net assets of Kansas City Life Variable Annuity Separate Account (comprising individual subaccounts as listed in note 1 to the financial statements) as of December 31, 2012, and the related statement of operations for the year or period then ended; the statements of changes in net assets for each of the years or periods in the two-year period then ended; and financial highlights for each of the years or periods in the five-year period then ended, which reports appear in the Statement of Additional Information accompanying the Prospectus of Century II Variable Annuity, included in the Post-Effective Amendment No. 23 of the Registration Statement under the Securities Exchange Act of 1933 (File No. 333-89984) on Form N-4 and to the reference to our firm under the heading “Experts”, also in the Statement of Additional Information.


 


As discussed in note 3 to the consolidated financial statements, effective January 1, 2012, the Company modified the types of costs incurred that can be capitalized when issuing or renewing insurance contracts due to the prospective adoption of Financial Accounting Standards Board Accounting Standards Update (ASU) No. 2010-26, Accounting for Costs associated with Acquiring or Renewing Insurance Contracts.


 


/s/ KPMG LLP


 


Kansas City, Missouri


April 30, 2013
ex4-21.htm









Exhibit 4.21




 


SUMMARY OF CREDIT LINE AGREEMENT BETWEEN CHINA BANK OF COMMUNICATIONS GUILIN BRANCH AND GUILIN JUN TAI FU CONSTRUCTION AND DEVELOPMENT CO. LTD.


 


In May 2012, China Bank of Communications Guilin Branch (the “Bank”) entered into agreement with Guilin Jun Tai Fu Construction and Development Co. Ltd. (the “Company”).


 


The Bank granted the Company a revolving credit line in the amount of RMB 40 million to fund operations and procure materials after the completion of the manufacturing facility in Guilin. The revolving credit line is available for a term of 2 years.    Any loan made under the revolving credit line is due within 1 year from the date of the loan. The annual interest rate on the loan is fixed at the Bank of China’s benchmark rate at the time of the issuance of the loan plus 5%.


 


The Bank granted the Company a credit line in the amount of RMB 60 million to fund the development of the Company’s manufacturing facility in Guilin.  The credit line is available for a term of 1 year.  Any loan made under the credit line is due within 7 years from the date of the loan.  The annual interest rate on the loan is the Bank is fixed at the Bank of China’s benchmark rate at the time of the issuance of the loan plus 5%.


 


The Bank approved the Company’s request for a sight letter of credit in the amount of RMB 20 million that can be used within a 2 year period.  The Company must repay the Bank immediately for the credit issued. The letter of credit is for the procurement of equipment for the Company’s manufacturing facility in Guilin.  Applicable interest rate and fees will be according to the Bank’s policies.


 


The Bank approved the company’s request for a usance letter of credit in the amount of RMB 20 million that can be used within a 2 year period.  The Company has 1 year to pay the Bank for the credit issued.  The letter of credit is for the procurement of equipment for the Company’s manufacturing facility in Guilin.  Applicable interest rate and fees will be according to the Bank’s policies.


 


The credit lines are subject to the following material conditions:


 



	
  

	
●

	
The Company shall complete procedures to perfect the Bank’s security interests in the collateral and to make legally effective the Company’s guarantees to the Bank.








	
  

	
●

	
Prior to the release of the funds, the Company shall obtain a construction permit and ensure that it has completed procedures to comply with applicable laws and regulations.








	
  

	
●

	
The Company must invest its own funds and bank loan proceeds according to a pre-determined ratio; the Company must invest its own funds before investing bank loan proceeds (prior to the release of each loan, the amount invested by the Company (sans investments made using loan proceeds) must not be lower than 37% of the total investment).








	
  

	
●

	
The short term credit line (used for operations and letters of credit) can be tapped only after the manufacturing facility becomes operational.








	
  

	
●

	
The Company must abide by the terms and conditions set by the loan committee of the branch bank.
NeoMedia Technologies, Inc.



                                  Exhibit 10.49


            Termination of Collateralized Guaranty Between IBM Credit
      Corporation, Gen-Tech, Inc. and Dev-Mark, Inc. Dated February 5, 1997

<PAGE>

                                     IBM
-----------------------------------------------------------------------------
IBM Credit Corporation            2707 Butterfield Road
                                     Oak Brook, IL 60521
                                     800-753-7053


February 5, 1997

                           CERTIFIED MAIL/RETURN RECEIPT REQUESTED


Mr. Charles W. Fritz
NeoMedia Technologies, Inc
2201 Second Street, Suite 600
Fort Myers, FL 33901

RE:  Termination of Collateralized Guaranty

Dear Mr. Fritz:

IBM CREDIT CORPORATION ("IBM Credit") hereby acknowledges receipt of your
request to terminate the Collateralized Guaranty from Gen-Tech, Inc., and
Dev-Mark, Inc., of the obligations of NeoMedia Technologies, Inc. (Dealer)
executed by you on August 16, 1994.

Please be advised that according to the terms of the Guaranty, the termination
will be effective sixty (60) days after receipt and acknowledgment by IBM
Credit. The termination does not affect your guaranty of liabilities (as defined
in the Guaranty) prior to the effective date of termination.

The effective date of termination shall be April 5, 1997. You will be obligated
to pay all Liabilities incurred prior to this date.

Please do not hesitate to contact the undersigned if you have any questions.

Sincerely,
/s/ SAGE K. RANDRUP
-------------------
Sage K. Randrup
Credit Manager

SKR/klm

Enclosure
I 

111TH CONGRESS 

1ST SESSION H. R. 3596 

To ensure that health insurance issuers and medical malpractice insurance 

issuers cannot engage in price fixing, bid rigging, or market allocations 

to the detriment of competition and consumers. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 17, 2009 

Mr. CONYERS (for himself, Mr. JOHNSON of Georgia, and Ms. DEGETTE) introduced the following bill; which was referred to the Committee on the 

Judiciary 

A BILL 

To ensure that health insurance issuers and medical malpractice insurance issuers cannot engage in price fixing, 

bid rigging, or market allocations to the detriment of 

competition and consumers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Insurance In5 dustry Antitrust Enforcement Act of 2009’’. 

6 SEC. 2. PURPOSE. 

7 It is the purpose of this Act to ensure that health 

8 insurance issuers and medical malpractice insurance 


wwoods2 on DSK1DXX6B1PROD with BILLS
2 

•HR 3596 IH

1 issuers cannot engage in price fixing, bid rigging, or mar2 ket allocations to the detriment of competition and con3 sumers. 

4 SEC. 3. PROHIBITION OF ANTI-COMPETITIVE ACTIVITIES. 

5 Notwithstanding any other provision of law, nothing 

6 in the Act of March 9, 1945 (15 U.S.C. 1011 et seq., com7 monly known as the ‘‘McCarran-Ferguson Act’’), shall be 

8 construed to permit health insurance issuers (as defined 

9 in section 2791 of the Public Health Service Act (42 

10 U.S.C. 300gg–91) or issuers of medical malpractice insur11 ance to engage in any form of price fixing, bid rigging, 

12 or market allocations in connection with the conduct of 

13 the business of providing health insurance coverage (as de14 fined in such section) or coverage for medical malpractice 

15 claims or actions. 

16 SEC. 4. APPLICATION TO ACTIVITIES OF STATE COMMIS17 SIONS OF INSURANCE AND OTHER STATE IN18 SURANCE REGULATORY BODIES. 

19 Nothing in this Act shall apply to the information 

20 gathering and rate setting activities of any State commis21 sion of insurance, or any other State regulatory entity 

22 with authority to set insurance rates. 

Æ 


wwoods2 on DSK1DXX6B1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Deposit Insurance Corporation

*Notice is hereby given*                     that the Federal Deposit Insurance Corporation (“FDIC”) as Receiver for Ameribank, Inc., Northfolk, West Virginia (“the Receiver”) intends to terminate its receivership for said institution. The FDIC was appointed receiver of Ameribank, Inc. on September 19, 2008. The liquidation of the receivership assets has been completed. To the extent permitted by available funds and in accordance with law, the Receiver will be making a final dividend payment to proven creditors.                

Based upon the foregoing, the Receiver has determined that the continued existence of the receivership will serve no useful purpose. Consequently, notice is given that the receivership shall be terminated, to be effective no sooner than thirty days after the date of this Notice. If any person wishes to comment concerning the termination of the receivership, such comment must be made in writing and sent within thirty days of the date of this Notice to: Federal Deposit Insurance Corporation, Division of Resolutions and Receiverships, Attention: Receivership Oversight Department 32.1, 1601 Bryan Street, Dallas, TX 75201.

No comments concerning the termination of this receivership will be considered which are not sent within this time frame.

Dated: April 6, 2015.

Federal Deposit Insurance Corporation.

Robert E. Feldman,

Executive Secretary.

[FR Doc. 2015-08191 Filed 4-9-15; 8:45 am]

 BILLING CODE 6714-01-P
THE THIRTEENTH COURT OF APPEALS

13-21-00395-CV

Siegfried Pueblitz, M.D.

v.

Tom Ray Lemen

On Appeal from the

93rd District Court of Hidalgo County, Texas

Trial Court Cause No. C-0959-21-B

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appellant’s amended petition for permissive interlocutory appeal concludes that 

appellant has not shown his entitlement to permissive interlocutory appeal. Accordingly,

the amended petition for permissive interlocutory appeal is DENIED in accordance with 

its opinion. Costs of the appeal are adjudged against appellant.

We further order this decision certified below for observance.

December 21, 2021
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                                        <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      48,625,105
<SECURITIES>                                 5,764,060
<RECEIVABLES>                               13,597,389
<ALLOWANCES>                                 2,982,676
<INVENTORY>                                  4,145,399
<CURRENT-ASSETS>                            69,568,923
<PP&E>                                       7,054,242
<DEPRECIATION>                               3,054,094
<TOTAL-ASSETS>                              73,826,523
<CURRENT-LIABILITIES>                        8,968,089
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        19,607
<OTHER-SE>                                  64,080,137
<TOTAL-LIABILITY-AND-EQUITY>                73,826,523
<SALES>                                     25,517,528
<TOTAL-REVENUES>                            25,517,528
<CGS>                                       12,658,043
<TOTAL-COSTS>                               14,229,800
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,559,998)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,559,998)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,559,998)
<EPS-BASIC>                                      (.49)
<EPS-DILUTED>                                    (.49)


</TABLE>
exv4ws






THE UNITED STATES LIFE INSURANCE COMPANY IN THE CITY OF NEW YORK




ENDORSEMENT


Notwithstanding any provision in the Contract or Certificate (“Contract”) to the contrary, this
Endorsement becomes a part of the Contract to which it is attached. Should any provision in this
Endorsement conflict with the Contract, the provisions of this Endorsement will prevail.



Subject to the terms and conditions set forth herein this Endorsement provides additional
information to the Owner if the Contract was purchased in connection with the Premium Plus Program.





	1.	 	For purposes of this Endorsement, the following definitions apply. Terms not defined in this
Endorsement shall have the same meaning as defined in the Contract.






ELIGIBLE PERSON




Individuals named as Participants or Owners (“Owners”) of the Contract who are: (1)
employees of the Company or Our affiliates; (2) appointed agents, registered
representatives and employees of broker-dealers that sell Our variable annuity
contracts or the variable annuity contracts of Our affiliates; (3) trustees of mutual
funds offered in Our or Our affiliate’s variable annuity contracts; and (4) the
immediate family members of set forth in (1), (2) and (3).




IMMEDIATE FAMILY MEMBERS




The spouse, child, parent, parent-in-law, brother, brother-in-law, sister or
sister-in-law of an individual identified in items (1), (2) and (3) of the definition
of Eligible Person, or such other family member as We may approve.




YOU, YOUR




The Eligible Person(s) under this Endorsement.




	2.	 	The following paragraph is added to the PURCHASE PAYMENT PROVISIONS of the Contract:






We will credit an additional amount to Contracts sold to an Eligible Person. The
additional amount credited to a Contract sold to one of the above individuals will
generally equal the commission payable on the Initial Purchase Payment of the
Contract. If any subsequent Purchase Payments are received under the Contract, an
additional amount generally equal to the commission payable on any subsequent
Purchase Payments received will be credited to the Contract.



					
	 	 	 	 	 
	FSE-6245 (12/08)
	 	1
	 	 






 









 









If, after purchasing the Contract to which this Endorsement is part, You choose to
exercise Your Right to Examine shown on page 1 of the Contract, the amount refunded
to You will not include the additional amount credited as the result of this program.


This Endorsement is signed by the Company to be effective on the later of the Contract Effective
Date or [ DATE ]¬1.




THE UNITED STATES LIFE INSURANCE COMPANY IN THE CITY OF NEW YORK




 ¬2




					
	 	 	 	 	 
	FSE-6245 (12/08)
	 	2